dimethylarginine

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Reactive oxygen species (ROS) are reactive intermediates of molecular oxygen that act as important second messengers within the… (More)
Is this relevant?
Review
2017
Review
2017
Asymmetric and symmetric dimethylarginine (ADMA and SDMA, respectively) are toxic, non-proteinogenic amino acids formed by post… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2004
Review
2004
Asymmetrical Dimethylarginine : The Über Marker? Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2004 American Heart… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND NO is a major regulator of cardiovascular physiology that reduces vascular and cardiac contractility. Accumulating… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND An endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (ADMA), is elevated in patients with… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Hyperhomocysteinemia is a putative risk factor for cardiovascular disease, which also impairs endothelium-dependent… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The survival of motor neurons protein (SMN), the product of the neurodegenerative disease spinal muscular atrophy (SMA) gene… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Asymmetrical dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor. It is formed by protein arginine N… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 2
  • figure 7
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS). Plasma levels of ADMA… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthase. Because… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?